SCHEMBL6040933

SCHEMBL6040933

CCOC(CO)Oc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
LMNA P02545 2/20 0.37
ALDH1A1 P00352 3/20 0.36
RECQL P46063 1/20 0.36
TDP1 Q9NUW8 2/20 0.36
PPARG P37231 2/20 0.35
PPARA Q07869 2/20 0.35
TSHR P16473 2/20 0.35
MAPK1 P28482 1/20 0.35
PPARD Q03181 1/20 0.35
SLC6A4 P31645 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5503141 0.84 LTA4H (0.41) LTA4HL3MBTL1MTNR1AMTNR1BLMNA
SCHEMBL675062 0.83 ALDH1A1 (0.44) LTA4HMTNR1AMTNR1BLMNAALDH1A1
SCHEMBL28687387 0.81 PPARA (0.39) PPARGPPARATSHRSLC6A4GAA
SCHEMBL15509335 0.81 LTA4H (0.38) LTA4HL3MBTL1MTNR1AMTNR1BLMNA
SCHEMBL8486652 0.81 LTA4H (0.38) LTA4HL3MBTL1MTNR1AMTNR1BLMNA
SCHEMBL1579516 0.81 SLC6A4 (0.39) LTA4HL3MBTL1MTNR1AMTNR1BTDP1
SCHEMBL29138031 0.81 LTA4H (0.38) LTA4HL3MBTL1MTNR1AMTNR1BSLC6A4
SCHEMBL11405573 0.81 LTA4H (0.38) LTA4HL3MBTL1MTNR1AMTNR1BLMNA
SCHEMBL28331349 0.81 LTA4H (0.38) LTA4HL3MBTL1MTNR1AMTNR1BLMNA
SCHEMBL1412775 0.81 ALDH1A1 (0.50) LTA4HMTNR1AMTNR1BLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117645531-A Preparation method of p-tert-octyl phenoxy ethoxy ethyl chloride 扬州市普林斯医药科技有限公司 2024-03-05 CN disclosed
CN-111132549-A Long-acting control agent for ectoparasites of animals 三井化学AGRO株式会社 2020-05-08 CN disclosed
EP-3569591-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SABIC Global Technologies B.V. (NL) 2019-11-20 EP disclosed
US-20190337895-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2019-11-07 US disclosed
US-10435368-B2 High heat monomers and methods of use thereof SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2019-10-08 US disclosed
EP-3172188-B1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SABIC GLOBAL TECHNOLOGIES BV (NL) 2019-09-04 EP disclosed
US-20170166528-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2017-06-15 US disclosed
EP-3172188-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SABIC Global Technologies B.V. (NL) 2017-05-31 EP disclosed
WO-2016014629-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2016-01-28 WO disclosed
US-20060008807-A1 Multiparameter analysis of comprehensive nucleic acids and morphological features on the same sample VERIDEX, LLC 2006-01-12 US disclosed
EP-1438419-A2 MULTIPARAMETER ANALYSIS OF COMPREHENSIVE NUCLEIC ACIDS AND MORPHOLOGICAL FEATURES ON THE SAME SAMPLE IMMUNIVEST CORPORATION (US) 2004-07-21 EP disclosed
EP-1438398-A2 MULTIPARAMETER ANALYSIS OF COMPREHENSIVE NUCLEIC ACIDS AND MORPHOLOGICAL FEATURES ON THE SAME SAMPLE IMMUNIVEST CORPORATION (US) 2004-07-21 EP disclosed
WO-2003035895-A2 MULTIPARAMETER ANALYSIS OF COMPREHENSIVE NUCLEIC ACIDS AND MORPHOLOGICAL FEATURES ON THE SAME SAMPLE IMMUNIVEST CORPORATION (US) 2003-05-01 WO disclosed
WO-2003035894-A2 MULTIPARAMETER ANALYSIS OF COMPREHENSIVE NUCLEIC ACIDS AND MORPHOLOGICAL FEATURES ON THE SAME SAMPLE IMMUNIVEST CORPORATION (US) 2003-05-01 WO disclosed
EP-1178973-A2 NOVEL COMPOUNDS, THEIR USE AND PREPARATION Pharmacia AB (SE) 2002-02-13 EP disclosed
WO-2000076984-A2 NOVEL COMPOUNDS, THEIR USE AND PREPARATION BIOVITRUM AB (SE) 2000-12-21 WO disclosed
EP-0264192-B1 Direct positive silver halide light-sensitive photographic material KONISHIROKU PHOTO IND (JP) 1994-03-30 EP disclosed
US-4215067-A HAZE-FREE, OIL ADDITIVES STANDARD OIL COMPANY (INDIANA) (US) 1980-07-29 US disclosed
US-4072528-A Oxygen barrier layers for photopolymerizable elements E. I. DU PONT DE NEMOURS AND COMPANY (US) 1978-02-07 US disclosed
US-4072527-A Oxygen barrier layers for photopolymerizable elements E. I. DU PONT DE NEMOURS AND COMPANY (US) 1978-02-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190337895-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF HSP90AA1, HSP90AB1, HSPBP1 LTA4H 2343/4885L3MBTL1 3443/4885MTNR1A 4612/4885
US-20170166528-A1 HIGH HEAT MONOMERS AND METHODS OF USE THEREOF HSP90AA1, HSP90AB1, HSPBP1 LTA4H 2343/4885L3MBTL1 3443/4885MTNR1A 4612/4885
US-10435368-B2 High heat monomers and methods of use thereof HSP90AA1, HSP90AB1, HSPBP1 LTA4H 2343/4885L3MBTL1 3443/4885MTNR1A 4612/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.